Table 2.
Description | State | Without movement | With movement | ||
---|---|---|---|---|---|
Low | High | Low | High | ||
Uninfected and untreated | S | 34.269% | 0.027% | 1.265% | 0.079% |
S a | 2.725% | 0.234% | 7.414% | 0.363% | |
Infected but untreated | A | 3.156% | 0.111% | 0.161% | 0.307% |
A a | 0.310% | 2.658% | 1.439% | 3.533% | |
Immune-protected but uninfected | P | 7.949% | 0.539% | 0.973% | 1.042% |
P a | 10.137% | 86.450% | 79.764% | 82.184% | |
Infected and treated | D | 0.824% | 0.103% | 0.054% | 0.270% |
D a | 0.089% | 0.765% | 0.420% | 1.011% | |
Infected prior to treatment | T 1 | 8.550% | 1.063% | 1.279% | 2.087% |
with drug in bloodstream | T 3 | 1.310% | 0.092% | 0.172% | 0.216% |
Uninfected prior to treatment | T a | 0.925% | 7.936% | 6.324% | 8.528% |
with drug in bloodstream | T 2 | 28.450% | 0.022% | 0.735% | 0.380% |
All results are based on model parameters as summarized in Additional file 2: Table S3, with p 21 /p 21 = 1 = m, p12 = 0.02. Note that the values for T 1, T 2, T 3 and T a represent the sum of T 1 and T' 1, T 2 and T' 2, T 3 and T' 3, and T a and T' a respectively.